CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-31 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,061 | 107,245 | ||
| 2016-12-31 | LEBEL FRANCOIS Executive Vice President R&D | Shares withheld for taxes | −21,667 | $5.35 | $116K | 137,683 |
| 2016-12-31 | Lafond Kevin G Vice Pres., Treasurer & CAO | Shares withheld for taxes | −9,333 | $5.35 | $50K | 57,967 |
| 2016-12-31 | Cooper Laurence James Neil Chief Executive Officer | Shares withheld for taxes | −17,292 | $5.35 | $93K | 1,209,291 |
| 2016-12-31 | BELBEL CAESAR J COO, CLO, and Secretary | Shares withheld for taxes | −21,667 | $5.35 | $116K | 190,217 |
| 2016-12-31 | CANNON JAMES ANTHONY Director | Shares withheld for taxes | −6,665 | $5.35 | $36K | 352,502 |
| 2016-12-31 | Fowler Wyche Director | Shares withheld for taxes | −10,664 | $5.35 | $57K | 140,850 |
| 2016-12-31 | WEISER MICHAEL Director | Shares withheld for taxes | −9,331 | $5.35 | $50K | 203,670 |
| 2016-12-31 | BRENNAN MURRAY Director | Shares withheld for taxes | −10,558 | $5.35 | $56K | 53,114 |
| 2016-12-30 | LEBEL FRANCOIS Executive Vice President R&D | Grant or award | +94,350 | 159,350 | ||
| 2016-12-30 | Lafond Kevin G Vice Pres., Treasurer & CAO | Grant or award | +39,300 | 67,300 | ||
| 2016-12-30 | Cooper Laurence James Neil Chief Executive Officer | Grant or award | +212,250 | 1,226,583 | ||
| 2016-12-30 | BELBEL CAESAR J COO, CLO, and Secretary | Grant or award | +94,350 | 211,884 | ||
| 2016-12-30 | CANNON JAMES ANTHONY Director | Grant or award | +17,204 | 359,167 | ||
| 2016-12-30 | Tarriff Scott Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-12-30 | Fowler Wyche Director | Grant or award | +17,204 | 151,514 | ||
| 2016-12-30 | WEISER MICHAEL Director | Grant or award | +17,204 | 213,001 | ||
| 2016-12-30 | BRENNAN MURRAY Director | Grant or award | +17,204 | 63,672 | ||
| 2016-12-30 | KIRK RANDAL J Director | Grant or award | +17,204 | 139,513 | ||
| 2016-12-30 | KIRK RANDAL J Director | Other acquisition · Series 1 Preferred Stock | +1,051 | 106,184 |
Page 15 of 16 · 304 trades